- Home
- PROF vs BIOA Comparison
PROF vs BIOA Comparison
Compare PROF & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- BIOA
- Stock Information
- Founded
- PROF N/A
- BIOA 2015
- Country
- PROF Canada
- BIOA United States
- Employees
- PROF N/A
- BIOA N/A
- Industry
- PROF Medical/Dental Instruments
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- BIOA Health Care
- Exchange
- PROF Nasdaq
- BIOA Nasdaq
- Market Cap
- PROF 164.4M
- BIOA 144.1M
- IPO Year
- PROF N/A
- BIOA 2024
- Fundamental
- Price
- PROF $4.27
- BIOA $3.99
- Analyst Decision
- PROF Strong Buy
- BIOA Hold
- Analyst Count
- PROF 2
- BIOA 4
- Target Price
- PROF $11.50
- BIOA $5.67
- AVG Volume (30 Days)
- PROF 79.0K
- BIOA 224.6K
- Earning Date
- PROF 05-08-2025
- BIOA 05-06-2025
- Dividend Yield
- PROF N/A
- BIOA N/A
- EPS Growth
- PROF N/A
- BIOA N/A
- EPS
- PROF N/A
- BIOA N/A
- Revenue
- PROF $11,862,000.00
- BIOA $1,451,000.00
- Revenue This Year
- PROF $71.17
- BIOA N/A
- Revenue Next Year
- PROF $134.25
- BIOA N/A
- P/E Ratio
- PROF N/A
- BIOA N/A
- Revenue Growth
- PROF 75.01
- BIOA N/A
- 52 Week Low
- PROF $3.90
- BIOA $2.88
- 52 Week High
- PROF $11.42
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- PROF 34.68
- BIOA N/A
- Support Level
- PROF $4.62
- BIOA N/A
- Resistance Level
- PROF $5.62
- BIOA N/A
- Average True Range (ATR)
- PROF 0.42
- BIOA 0.00
- MACD
- PROF -0.01
- BIOA 0.00
- Stochastic Oscillator
- PROF 8.45
- BIOA 0.00
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.